CDSCO issued the list of drugs declared as Not of Standard Quality (NSQ) Alert for the Month of January 2025

Mar 06, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe Central Drugs Standard Control Organization (CDSCO) on February 28, 2025, issued the list of drugs declared as Not of Standard Quality (NSQ) Alert for the Month of January 2025.

It is stated that the drugs that fail to meet the quality standards or specifications are known as Not of Standard Quality (NSQ) drugs.

The following drugs declared as Not of Standard Quality (NSQ):

• Monopropylene Glycol USP - M/s. Shell Eastern Chemicals, the Metropolis Tower 1, 9, North Buona Vista Drive#0701, Singapore-138588

• Ticagrelor Tablets IP 90 mg (Tigamon 90) - M/s. MONIQUE PHARMACEUTICAL S PVT. LTD., Plot No-676, Sector-69, IMT, Faridabad, Haryana-121004

• Calcium Aspartate, Calcium Orotate, Calcitriol, Minerals And Vitamins Tablets - M/s. Overseas Healthcare Pvt. Ltd., 335 Km Milestone, National Highway No.1, P.O. Box-25, Phillaur-144410 (Pb)

• Diclofenac Sodium Injection I.P (DEPAIN-75) - M/s. Srinija Parenterals, D.No. 283, Doctors Estate, Perecherla 522 009

• Iron Sucrose Injection USP 100mg/5ml - M/s. SAI Parenterals Limited, D1 & D4, Survey No.280, Phase-V, IDA, Jeedimetla, Hyderabad500055.TS 

• Iron Sucrose Injection USP 100mg/5ml - M/s. SAI Parenterals Limited, D1 &D4, Survey No.280, Phase-V, IDA, Jeedimetla, Hyderabad500055.TS


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT